Application

15943936 · Treatment of NAFLD and NASH

Filed 2018-04-03 · Granted · Patent 10188620 (2019-01-29) The official file ↗The patent and its PDF ↗ · Art unit 1625 · Examiner Heidi L Reese Easy · CPC A61K 31/192 · CymaBay Therapeutics, Inc. · Gilead Sciences, Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.3 mo

to disposition 9.9 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.